Eric. T. Romeo is an associate in Goodwin’s IP Litigation group, with a focus on pharmaceutical patent litigation (Hatch-Waxman). Mr. Romeo has worked with clients on intellectual property issues in the pharmaceutical, chemical, biological, and high-technology industries. Mr. Romeo specializes in working with expert and technical witnesses in the biology and chemistry space. Beyond litigation, Mr. Romeo’s experience includes patent prosecution, inter partes review proceedings, and freedom to operate analysis. Mr. Romeo also devotes significant time to representing pro bono clients in criminal and immigration matters.

Areas of Practice
TÄTIGKEITSFELDER
业务范围
Scientific Experience

Experience

ERFAHRUNG

工作经历

Professional Experience

Prior to joining Goodwin, Mr. Romeo worked as a medicinal chemist at Merck Research Laboratories. While at Merck, Mr. Romeo designed and synthesized drug compounds to treat cancer, Alzheimer’s disease, asthma, and schizophrenia. Mr. Romeo is named as an inventor on a number of Merck patents and performed the first synthesis of MK-8351, a novel asthma drug that progressed into clinical development.

Some of Mr. Romeo’s recent representations include:

  • In re Bendamustine Consolidated Cases: Representing Cephalon, Inc. in patent litigation against 18 defendants involving Cephalon’s branded cancer drug, Treanda®. The U.S. District Court for the District of Delaware issued a final decision in favor of Cephalon, upholding the validity and finding infringement of all patents-in-suit following a bench trial. The case is now on appeal.
  • Coalition for Affordable Drugs VIII, LLC v. The Trustees of the University of Pennsylvania: Represented patent owner, the Trustees of the University of Pennsylvania, in an inter partes review proceeding involving patents directed to the treatment of hypercholesterolemia and hyperlipidemia with a novel dosing regimen for the drug lomitapide. The PTAB issued a final decision in favor of the patent owner, upholding the validity of the patent-in-suit.
  • Merck, Sharpe & Dohme Corp. v. Actavis Laboratories FL, Inc.: Represented Actavis as ANDA-defendant in patent litigation involving Merck’s branded antifungal drug Noxafil® (posaconazole).  Following a bench trial in the U.S. District Court for the District of New Jersey, the case was settled favorably.
  • Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC: Representing Fresenius Kabi and Actavis as ANDA-defendants in patent litigation involving Sanofi’s branded cancer drug Jevtana® (cabazitaxel).  Following a bench trial, the case is currently pending in the U.S. District Court for the District of New Jersey.
  • Representation of an 11-year-old client from El Salvador in federal immigration proceedings. The client was granted asylum in the United States in July 2016. In 2017, Goodwin received the Adams Pro Bono Publico Award from the Massachusetts Supreme Judicial Court for, among other activities, the firm’s work on this asylum case.
  • Preparation of clemency petitions for several federal inmates serving long sentences for narcotics violations. In 2016, President Obama granted clemency to three of Mr. Romeo’s clients, two of which were serving life sentences.
     

Credentials

WERDEGANG

专业资格

Education

J.D., 2014
Harvard Law School
B.S., Biochemistry, 2007
Boston College

Admissions

Bar

U.S. Patent and Trademark Office (USPTO)
Massachusetts

Courts

U.S. District Court for the District of Massachusetts
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师